Literature DB >> 9502660

Recommendations for the assessment and maintenance of proficiency in coronary interventional procedures: Statement of the American College of Cardiology.

J W Hirshfeld, S G Ellis, D P Faxon.   

Abstract

Mesh：

Year:  1998        PMID： 9502660     DOI： 10.1016/s0735-1097(98)00009-6

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN： 0735-1097            Impact factor:   24.094


× No keyword cloud information.
  9 in total

1.  Quality improvement guidelines for the performance of cervical carotid angioplasty and stent placement.

Authors:  John D Barr; John J Connors; David Sacks; Joan C Wojak; Gary J Becker; John F Cardella; Bohdan Chopko; Jacques E Dion; Allan J Fox; Randall T Higashida; Robert W Hurst; Curtis A Lewis; Terence A S Matalon; Gary M Nesbit; J Arliss Pollock; Eric J Russell; David J Seidenwurm; Robert C Wallace
Journal:  AJNR Am J Neuroradiol       Date:  2003 Nov-Dec       Impact factor: 3.825

Review 2.  Training, competency, and credentialing standards for diagnostic cervicocerebral angiography, carotid stenting, and cerebrovascular intervention.

Authors:  John J Connors; David Sacks; Anthony J Furlan; Warren R Selman; Eric J Russell; Philip E Stieg; Mark N Hadley
Journal:  AJNR Am J Neuroradiol       Date:  2004 Nov-Dec       Impact factor: 3.825

3.  Complications of diagnostic cardiac catheterisation: results from a confidential inquiry into cardiac catheter complications.

Authors:  R West; G Ellis; N Brooks
Journal:  Heart       Date:  2005-11-24       Impact factor: 5.994

4.  Dutch guidelines for interventional cardiology: institutional and operator competence and requirements for training.

Authors:  W R M Aengevaeren; G J Laarman; M J Suttorp; J M Ten Berg; A J van Boven; M J de Boer; J J Piek; G V A van Ommen; J G F Bronzwaer; P Smits; J W Deckers
Journal:  Neth Heart J       Date:  2005-11       Impact factor: 2.380

5.  Hospital volume of throughput and periprocedural and medium-term adverse events after percutaneous coronary intervention: retrospective cohort study of all 17,417 procedures undertaken in Scotland, 1997-2003.

Authors:  K R Burton; R Slack; K G Oldroyd; A C H Pell; A D Flapan; I R Starkey; H Eteiba; K P Jennings; R J Northcote; W Stewart Hillis; J P Pell
Journal:  Heart       Date:  2006-05-18       Impact factor: 5.994

6.  Preconditioning reduces QTc value in patients with first non-ST-segment elevation myocardial infarction (NSTEMI).

Authors:  Christodoulos E Papadopoulos; Haralampos I Karvounis; Georgios E Parharidis; Georgios E Louridas
Journal:  Ann Noninvasive Electrocardiol       Date:  2003-10       Impact factor: 1.468

7.  Position Statement of the Brazilian Cardiology Society and the Brazilian Society of Hemodynamics and Interventional Cardiology on Training Centers and Professional Certification in Hemodynamics and Interventional Cardiology - 2020.

Authors:  José Airton de Arruda; Viviana de Mello Guzzo Lemke; José Mariani Júnior; Adriano Henrique Pereira Barbosa; Alexandre Schaan de Quadros; Carlos Augusto Cardoso Pedra; Cristiano de Oliveira Cardoso; Ênio Eduardo Guérios; Henrique Barbosa Ribeiro; Luiz Antonio Gubolino; Maurício Cavalieri Machado; Mauricio Jaramillo Hincapie; Nelson Antonio Moura de Araujo; Raul Ivo Rossi Filho; Ricardo Alves da Costa; Silvio Gioppato
Journal:  Arq Bras Cardiol       Date:  2020-01       Impact factor: 2.000

8.  Hospital Volume Threshold Associated with Higher Survival after Endovascular Recanalization Therapy for Acute Ischemic Stroke.

Authors:  Dong-Hyun Shim; Youngsoo Kim; Jieun Roh; Jongsoo Kang; Kyung-Pil Park; Jae-Kwan Cha; Seung Kug Baik; Yoon Kim
Journal:  J Stroke       Date:  2020-01-31       Impact factor: 6.967

9.  Performance and training standards for endovascular ischemic stroke treatment.

Authors:  P M Meyers; H C Schumacher; M J Alexander; C P Derdeyn; A J Furlan; R T Higashida; C J Moran; R W Tarr; D V Heck; J A Hirsch; M E Jensen; I Linfante; C G McDougall; G M Nesbit; P A Rasmussen; T A Tomsick; L R Wechsler; J R Wilson; O O Zaidat
Journal:  AJNR Am J Neuroradiol       Date:  2010-01       Impact factor: 4.966
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.